Exponent nears Chanelle Pharm acquisition
UK-based Exponent is closing in on the acquisition of Chanelle Pharm in a deal thought to be worth at least €300m, according to The Sunday Times.
UK-based Exponent is closing in on the acquisition of Chanelle Pharm in a deal thought to be worth at least €300m, according to The Sunday Times.